Personalized Concurrent Exercise for Cardiovascular Risk Control and Fitness in Adults
NCT ID: NCT06509282
Last Updated: 2024-07-19
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
39 participants
Study Classification
INTERVENTIONAL
Study Start Date
2023-12-29
Study Completion Date
2024-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: To determine the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment compared to pharmacological treatment alone in controlling cardiovascular risk factors and physical capacity in adults enrolled in a Cardiovascular Health Program.
Research Design: This pilot randomized controlled clinical trial (RCT) evaluates the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment versus pharmacological treatment alone. Outcomes: blood pressure, fasting glucose, total cholesterol, and triglycerides, muscle strength, cardiorespiratory capacity, body composition, adherence to the exercise guide, and patient perception of intervention effects, sociodemographic and medical background, physical activity level, Population: Adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia will be recruited during regular check-up hours. Detailed study information will be provided, and informed consent obtained.
Sample Size: The sample size is 15 subjects per group, accounting for a 30% dropout rate, resulting in 39 participants. Participants will be randomly assigned to experimental (EG) or control groups (CG) with a 1:1 allocation ratio. Allocation concealment will be ensured with opaque, sealed envelopes.
Evaluations: Pre- and post-intervention evaluations will be conducted in both groups. Sociodemographic and medical background information will be collected through clinical record reviews. Blood pressure, heart rate, glucose, triglycerides, cholesterol, adherence to the exercise guide, and patient perception of intervention effects will be measured using standardized procedures by trained kinesiologists.
Research Design: This pilot randomized controlled clinical trial (RCT) evaluates the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment versus pharmacological treatment alone. Outcomes: blood pressure, fasting glucose, total cholesterol, and triglycerides, muscle strength, cardiorespiratory capacity, body composition, adherence to the exercise guide, and patient perception of intervention effects, sociodemographic and medical background, physical activity level, Population: Adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia will be recruited during regular check-up hours. Detailed study information will be provided, and informed consent obtained.
Sample Size: The sample size is 15 subjects per group, accounting for a 30% dropout rate, resulting in 39 participants. Participants will be randomly assigned to experimental (EG) or control groups (CG) with a 1:1 allocation ratio. Allocation concealment will be ensured with opaque, sealed envelopes.
Evaluations: Pre- and post-intervention evaluations will be conducted in both groups. Sociodemographic and medical background information will be collected through clinical record reviews. Blood pressure, heart rate, glucose, triglycerides, cholesterol, adherence to the exercise guide, and patient perception of intervention effects will be measured using standardized procedures by trained kinesiologists.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance and/or Endurance Training, What is Most Effective in Prevention of Cardiovascular Diseases?
NCT00986024
Metabolic Syndrome
COMPLETED
NA
Physical Exercise on Physiological Adaptation Capacity and Chronic Pain in Individuals With Cardiovascular Risk
NCT06201273
Cardiometabolic Risk Factors
COMPLETED
NA
Predictors of Individual Training Effectiveness in Preventive Exercise
NCT00934206
Primary Prevention
COMPLETED
NA
Effect of Concurrent and Aerobic Exercise on VO2max, Strength, and Body Composition in Overweight and Obese Adults
NCT05867498
Healthy Volunteers
COMPLETED
NA
Cardiovascular Effects of Aerobic and Strength Training in Hypertensive Middle-aged Individuals
NCT03282942
Arterial Hypertension
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SCIENTIFIC COMPONENT, METHODOLOGY, ETHICS, AND PLANNING
RESEARCH QUESTION AND HYPOTHESIS Research Question What is the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment, compared to pharmacological treatment alone, in controlling cardiovascular risk factors and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024? Hypothesis H1: The efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment is greater than pharmacological treatment alone in controlling cardiovascular risk factors (CVRF) and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024. (group difference hypothesis) H0: The efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment is equal to pharmacological treatment alone in controlling CVRF and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024. (group difference hypothesis) Statistical Hypothesis
Group difference hypothesis:
* H0: μA = μB
* H1: μA \> μB OBJECTIVES General Objective To determine the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment, compared to pharmacological treatment alone, in controlling cardiovascular risk factors and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024.
2.2.2 Specific Objectives
* To describe the effects of applying a personalized concurrent exercise prescription guide on cardiovascular risk factors in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia.
* To describe the effects of applying a personalized concurrent exercise prescription guide on physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia.
* To evaluate adherence to the personalized concurrent exercise guide and pharmacological treatment in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia.
* To describe the clinical significance of the interventions through the calculation of effect size and the clinical relevance perceived by the participants regarding the interventions.
2.3 METHODOLOGY AND PROCEDURES Research Design The research design corresponds to a pilot randomized controlled clinical trial (RCT) with parallel groups and superiority. This design aligns with the general objective and proposed hypothesis, aiming to evaluate the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment, compared to pharmacological treatment alone, in controlling cardiovascular risk factors and physical capacity.
The primary study variables include blood pressure, fasting glucose, total cholesterol, and triglycerides, which are standard measurements for the Cardiovascular Health Program. Secondary variables include sociodemographic and medical background, level of physical activity, muscle strength, cardiorespiratory capacity, body composition, adherence to the exercise guide, and patient perception of changes experienced due to the intervention.
Population The study population will consist of adult users of the Cardiovascular Health Program (PSCV) enrolled in the External CESFAM in Valdivia. The research team will directly invite PSCV users during their regular check-up hours. Research professionals will be properly identified as staff from Universidad San Sebastián and will provide detailed information about the research, the exercise prescription guide application, program duration, benefits, and risks. Interested participants will be asked to sign informed consent. The recruitment period will last up to 1 month, extendable by another month if necessary to obtain the required sample size.
Sample Size Calculation
The sample size calculation is based on recommendations from the literature for pilot studies and includes:
* T-test - Means: difference between two independent means,
* Type I error: 5%,
* Statistical power: 80%,
* Effect size (ES): 0.5 according to Cohen's classification. Using these parameters, the recommended total sample size is fifteen subjects per group. Assuming a 30% dropout rate, the total population will correspond to thirty-nine participants. After the eligibility process, participants will be randomly assigned to an experimental group (EG) and a control group (CG) using a 1:1 allocation ratio through an online randomization system. Allocation concealment will be maintained using opaque, sealed, and consecutively numbered envelopes.
The experimental group will receive the intervention based on the personalized exercise prescription guide plus their usual pharmacological treatment associated with the PSCV, while the control group will maintain their usual pharmacological treatment associated with the PSCV.
Information Production Techniques All evaluations will be performed pre- and post-intervention in both the experimental and control groups.
Clinical Record Review:
The PSCV's responsible physician, with prior authorization from the External CESFAM's management and approval from the Valdivia Health Service Ethics Committee, will review the participants' medical records, collecting information on sociodemographic and medical background: sex, age, education, time in the cardiovascular health program, medical history, medications, dosage, and duration of medication use. These variables will be used to characterize the study sample.
Evaluations and follow-up will be conducted by trained Kinesiologists in evaluation techniques, exercise prescription, and cardiovascular risk factors, at the University of San Sebastián Health Center in Valdivia. A professional Kinesiologist will measure the variables, blinded to the participant's intervention assignment. These evaluations will encompass Cardiovascular Variables Evaluation, Cardiovascular Risk Factor, Metabolic Variables, Health-related Physical Capacity, Adherence to Treatment, and the Global Rating of Change Scale.
2.4 ANALYSIS OF ETHICAL IMPLICATIONS Risk-Benefit Analysis This study adheres to the Declaration of Helsinki, ensuring informed consent is obtained from all participants. The intervention will be conducted in both groups, with evaluations presenting minimal risk. Users may experience post-exercise muscle fatigue, which could last up to 48 hours, mitigated through education about exercise effects. The benefits include updated knowledge about participants' health status and physical capacity, with personalized exercise shown to effectively control cardiovascular risk factors.
Confidentiality Protection The clinical record review will be conducted at the External CESFAM by the PSCV responsible, and physical evaluations will be conducted at the University of San Sebastián Health Center. Participants will be assigned unique codes to preserve anonymity, with informed consent clearly stating data will not be used for purposes other than the study. Collected information will be stored securely by the Principal Investigator for 4 years, after which it will be handed over to the CESFAM. Only the research team will have access to the results.
RESEARCH QUESTION AND HYPOTHESIS Research Question What is the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment, compared to pharmacological treatment alone, in controlling cardiovascular risk factors and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024? Hypothesis H1: The efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment is greater than pharmacological treatment alone in controlling cardiovascular risk factors (CVRF) and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024. (group difference hypothesis) H0: The efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment is equal to pharmacological treatment alone in controlling CVRF and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024. (group difference hypothesis) Statistical Hypothesis
Group difference hypothesis:
* H0: μA = μB
* H1: μA \> μB OBJECTIVES General Objective To determine the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment, compared to pharmacological treatment alone, in controlling cardiovascular risk factors and physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia during 2024.
2.2.2 Specific Objectives
* To describe the effects of applying a personalized concurrent exercise prescription guide on cardiovascular risk factors in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia.
* To describe the effects of applying a personalized concurrent exercise prescription guide on physical capacity in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia.
* To evaluate adherence to the personalized concurrent exercise guide and pharmacological treatment in adult users of the Cardiovascular Health Program at the External CESFAM in Valdivia.
* To describe the clinical significance of the interventions through the calculation of effect size and the clinical relevance perceived by the participants regarding the interventions.
2.3 METHODOLOGY AND PROCEDURES Research Design The research design corresponds to a pilot randomized controlled clinical trial (RCT) with parallel groups and superiority. This design aligns with the general objective and proposed hypothesis, aiming to evaluate the efficacy of a personalized concurrent exercise prescription guide combined with pharmacological treatment, compared to pharmacological treatment alone, in controlling cardiovascular risk factors and physical capacity.
The primary study variables include blood pressure, fasting glucose, total cholesterol, and triglycerides, which are standard measurements for the Cardiovascular Health Program. Secondary variables include sociodemographic and medical background, level of physical activity, muscle strength, cardiorespiratory capacity, body composition, adherence to the exercise guide, and patient perception of changes experienced due to the intervention.
Population The study population will consist of adult users of the Cardiovascular Health Program (PSCV) enrolled in the External CESFAM in Valdivia. The research team will directly invite PSCV users during their regular check-up hours. Research professionals will be properly identified as staff from Universidad San Sebastián and will provide detailed information about the research, the exercise prescription guide application, program duration, benefits, and risks. Interested participants will be asked to sign informed consent. The recruitment period will last up to 1 month, extendable by another month if necessary to obtain the required sample size.
Sample Size Calculation
The sample size calculation is based on recommendations from the literature for pilot studies and includes:
* T-test - Means: difference between two independent means,
* Type I error: 5%,
* Statistical power: 80%,
* Effect size (ES): 0.5 according to Cohen's classification. Using these parameters, the recommended total sample size is fifteen subjects per group. Assuming a 30% dropout rate, the total population will correspond to thirty-nine participants. After the eligibility process, participants will be randomly assigned to an experimental group (EG) and a control group (CG) using a 1:1 allocation ratio through an online randomization system. Allocation concealment will be maintained using opaque, sealed, and consecutively numbered envelopes.
The experimental group will receive the intervention based on the personalized exercise prescription guide plus their usual pharmacological treatment associated with the PSCV, while the control group will maintain their usual pharmacological treatment associated with the PSCV.
Information Production Techniques All evaluations will be performed pre- and post-intervention in both the experimental and control groups.
Clinical Record Review:
The PSCV's responsible physician, with prior authorization from the External CESFAM's management and approval from the Valdivia Health Service Ethics Committee, will review the participants' medical records, collecting information on sociodemographic and medical background: sex, age, education, time in the cardiovascular health program, medical history, medications, dosage, and duration of medication use. These variables will be used to characterize the study sample.
Evaluations and follow-up will be conducted by trained Kinesiologists in evaluation techniques, exercise prescription, and cardiovascular risk factors, at the University of San Sebastián Health Center in Valdivia. A professional Kinesiologist will measure the variables, blinded to the participant's intervention assignment. These evaluations will encompass Cardiovascular Variables Evaluation, Cardiovascular Risk Factor, Metabolic Variables, Health-related Physical Capacity, Adherence to Treatment, and the Global Rating of Change Scale.
2.4 ANALYSIS OF ETHICAL IMPLICATIONS Risk-Benefit Analysis This study adheres to the Declaration of Helsinki, ensuring informed consent is obtained from all participants. The intervention will be conducted in both groups, with evaluations presenting minimal risk. Users may experience post-exercise muscle fatigue, which could last up to 48 hours, mitigated through education about exercise effects. The benefits include updated knowledge about participants' health status and physical capacity, with personalized exercise shown to effectively control cardiovascular risk factors.
Confidentiality Protection The clinical record review will be conducted at the External CESFAM by the PSCV responsible, and physical evaluations will be conducted at the University of San Sebastián Health Center. Participants will be assigned unique codes to preserve anonymity, with informed consent clearly stating data will not be used for purposes other than the study. Collected information will be stored securely by the Principal Investigator for 4 years, after which it will be handed over to the CESFAM. Only the research team will have access to the results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Cardiovascular Syndrome, Metabolic
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
TREATMENT
Blinding Strategy
TRIPLE
Caregivers
Investigators
Outcome Assessors
The concealment of allocation will be conducted by a researcher not involved in the clinical procedures of the intervention using the method of opaque, sealed, and consecutively numbered envelopes. The random sequence and allocation concealment allow for the control of selection bias.
For enhanced bias control, the data analysis will be performed by a researcher blinded to the intervention groups.
For enhanced bias control, the data analysis will be performed by a researcher blinded to the intervention groups.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Concurrent training
Concurrent training group
Group Type
EXPERIMENTAL
Concurrent training
Intervention Type
BEHAVIORAL
Protocol:
Duration: 6 weeks. Frequency: 3 times a week. Type: Concurrent. This consists of a combination of aerobic exercise and muscular resistance exercise.
Details of the type of exercise:
Aerobic exercise:
Participants will perform 5-10 intervals per session of walking or jogging at a moderate to high intensity, with a rating of 5 to 10 points on the modified Borg scale of 1-10 points. Each interval will consist of 1 minute of walking or jogging, followed by 2 minutes of inactive pause.
Muscular resistance exercise:
Participants will perform concentric and eccentric and/or isometric contractions for 1 minute at an intensity of 5-10 according to the OMNI-RES scale. The rest period will last 2 minutes, and each exercise will be repeated 3 times. Three exercises per session will be performed: squats, push-ups, and plank.
Pharmacological treatment:
Participants will be asked to maintain their lifestyle, including taking prescribed medication as usual.
Control
Control group
Group Type
NO_INTERVENTION
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Concurrent training
Protocol:
Duration: 6 weeks. Frequency: 3 times a week. Type: Concurrent. This consists of a combination of aerobic exercise and muscular resistance exercise.
Details of the type of exercise:
Aerobic exercise:
Participants will perform 5-10 intervals per session of walking or jogging at a moderate to high intensity, with a rating of 5 to 10 points on the modified Borg scale of 1-10 points. Each interval will consist of 1 minute of walking or jogging, followed by 2 minutes of inactive pause.
Muscular resistance exercise:
Participants will perform concentric and eccentric and/or isometric contractions for 1 minute at an intensity of 5-10 according to the OMNI-RES scale. The rest period will last 2 minutes, and each exercise will be repeated 3 times. Three exercises per session will be performed: squats, push-ups, and plank.
Pharmacological treatment:
Participants will be asked to maintain their lifestyle, including taking prescribed medication as usual.
Intervention Type
BEHAVIORAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Being physically inactive (not engaging in 300 or 150 minutes of moderate or vigorous intensity physical activity per week, respectively, as measured by the IPAQ questionnaire);
2. Body mass index between 25 and 39.9 kg/m²;
3. Enrolled in the Cardiovascular Health Program;
4. Diagnosis of hypertension with the use of 1 and/or 2 antihypertensive medications;
5. Diagnosis of Type 2 Diabetes Mellitus with the use of 1 oral hypoglycemic agent, non-insulin-dependent;
6. Diagnosis of dyslipidemia with the use of 1 lipid-lowering agent;
7. Possession of a telephone device.
2. Body mass index between 25 and 39.9 kg/m²;
3. Enrolled in the Cardiovascular Health Program;
4. Diagnosis of hypertension with the use of 1 and/or 2 antihypertensive medications;
5. Diagnosis of Type 2 Diabetes Mellitus with the use of 1 oral hypoglycemic agent, non-insulin-dependent;
6. Diagnosis of dyslipidemia with the use of 1 lipid-lowering agent;
7. Possession of a telephone device.
Exclusion Criteria
1. Bone disease;
2. Ischemic disease or arrhythmia;
3. Chronic respiratory disease;
4. Uncontrolled chronic diseases;
5. Inability to provide informed consent or comply with the tests and exercise protocol for any reason;
6. History of oncological disease or being under investigation for suspected neoplastic disease in any part of the body;
7. Female participants who are pregnant.
2. Ischemic disease or arrhythmia;
3. Chronic respiratory disease;
4. Uncontrolled chronic diseases;
5. Inability to provide informed consent or comply with the tests and exercise protocol for any reason;
6. History of oncological disease or being under investigation for suspected neoplastic disease in any part of the body;
7. Female participants who are pregnant.
Minimum Eligible Age
40 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad San Sebastián
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johnattan Cano Montoya
Principal Investigator
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnattan Cano Montoya, MSc.
Role: STUDY_CHAIR
Universidad San Sebastián
Johnattan Cano Montoya, MSc.
Role: STUDY_DIRECTOR
Universidad San Sebastián
Johnattan Cano Montoya, MSc.
Role: PRINCIPAL_INVESTIGATOR
Universidad San Sebastián
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad San Sebastián
Valdivia, Los Ríos Region, Chile
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Chile
References
Explore related publications, articles, or registry entries linked to this study.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020 Mar 7;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2. Epub 2019 Sep 3.
Reference Type
BACKGROUND
Nazzal C, Lefian A, Alonso F. [Incidence of acute myocardial infarction in Chile between 2008 and 2016]. Rev Med Chil. 2021 Mar;149(3):323-329. doi: 10.4067/s0034-98872021000300323. Spanish.
Reference Type
BACKGROUND
Parra-Soto S, Petermann-Rocha F, Martinez-Sanguinetti MA, Leiva-Ordenez AM, Troncoso-Pantoja C, Ulloa N, Diaz-Martinez X, Celis-Morales C. [Cancer in Chile and worldwide: an overview of the current and future epidemiological context]. Rev Med Chil. 2020 Oct;148(10):1489-1495. doi: 10.4067/S0034-98872020001001489. Spanish.
Reference Type
BACKGROUND
Celis-Morales C, Salas C, Martinez MA, Leiva AM, Garrido-Mendez A, Diaz-Martinez X. [The economic burden of physical inactivity in Chile]. Rev Med Chil. 2017 Aug;145(8):1091-1092. doi: 10.4067/s0034-98872017000801091. No abstract available. Spanish.
Reference Type
BACKGROUND
Pratt M, Macera CA, Wang G. Higher direct medical costs associated with physical inactivity. Phys Sportsmed. 2000 Oct;28(10):63-70. doi: 10.3810/psm.2000.10.1237.
Reference Type
BACKGROUND
Teo KK, Rafiq T. Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries. Can J Cardiol. 2021 May;37(5):733-743. doi: 10.1016/j.cjca.2021.02.009. Epub 2021 Feb 19.
Reference Type
BACKGROUND
Pucci GC, Rech CR, Fermino RC, Reis RS. Association between physical activity and quality of life in adults. Rev Saude Publica. 2012 Feb;46(1):166-79. doi: 10.1590/s0034-89102012000100021. English, Portuguese.
Reference Type
BACKGROUND
Geidl W, Schlesinger S, Mino E, Miranda L, Pfeifer K. Dose-response relationship between physical activity and mortality in adults with noncommunicable diseases: a systematic review and meta-analysis of prospective observational studies. Int J Behav Nutr Phys Act. 2020 Aug 26;17(1):109. doi: 10.1186/s12966-020-01007-5.
Reference Type
BACKGROUND
DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014 Jun;10(6):364-76. doi: 10.1038/nrendo.2014.44. Epub 2014 Apr 15.
Reference Type
BACKGROUND
Bergouignan A, Rudwill F, Simon C, Blanc S. Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies. J Appl Physiol (1985). 2011 Oct;111(4):1201-10. doi: 10.1152/japplphysiol.00698.2011. Epub 2011 Aug 11.
Reference Type
BACKGROUND
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
Reference Type
BACKGROUND
Diaz-Martinez X, Petermann F, Leiva AM, Garrido-Mendez A, Salas-Bravo C, Martinez MA, Labrana AM, Duran E, Valdivia-Moral P, Zagalaz ML, Poblete-Valderrama F, Alvarez C, Celis-Morales C. [Association of physical inactivity with obesity, diabetes, hypertension and metabolic syndrome in the chilean population]. Rev Med Chil. 2018 May;146(5):585-595. doi: 10.4067/s0034-98872018000500585. Spanish.
Reference Type
BACKGROUND
Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, Casanova A, Swaminathan S, Anjana RM, Kumar R, Rosengren A, Wei L, Yang W, Chuangshi W, Huaxing L, Nair S, Diaz R, Swidon H, Gupta R, Mohammadifard N, Lopez-Jaramillo P, Oguz A, Zatonska K, Seron P, Avezum A, Poirier P, Teo K, Yusuf S. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 2017 Dec 16;390(10113):2643-2654. doi: 10.1016/S0140-6736(17)31634-3. Epub 2017 Sep 21.
Reference Type
BACKGROUND
Cristi-Montero C, Ramirez-Campillo R, Alvarez C, Garrido Mendez A, Martinez MA, Diaz Martinez X, Leiva AM, Salas C, Gutierrez M, Sanzana-Inzunza R, Duran E, Labrana AM, Aguilar-Farias N, Celis-Morales C. [Inverse association of cardiorespiratory fitness with cardiovascular risk factors in Chilean adults]. Rev Med Chil. 2016 Aug;144(8):980-989. doi: 10.4067/S0034-98872016000800004. Spanish.
Reference Type
BACKGROUND
Arija V, Villalobos F, Pedret R, Vinuesa A, Timon M, Basora T, Aguas D, Basora J; Pas-a-Pas research group. Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the "Pas-a-Pas" community intervention trial. BMC Public Health. 2017 Jun 15;17(1):576. doi: 10.1186/s12889-017-4485-3.
Reference Type
BACKGROUND
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, Searle J, Trueman P, Taylor RS. Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ. 2011 Nov 4;343:d6462. doi: 10.1136/bmj.d6462.
Reference Type
BACKGROUND
Campbell F, Holmes M, Everson-Hock E, Davis S, Buckley Woods H, Anokye N, Tappenden P, Kaltenthaler E. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report. Health Technol Assess. 2015 Jul;19(60):1-110. doi: 10.3310/hta19600.
Reference Type
BACKGROUND
Williams NH, Hendry M, France B, Lewis R, Wilkinson C. Effectiveness of exercise-referral schemes to promote physical activity in adults: systematic review. Br J Gen Pract. 2007 Dec;57(545):979-86. doi: 10.3399/096016407782604866.
Reference Type
BACKGROUND
Cano-Montoya J, Ramirez-Campillo R, Sade Calles F, Izquierdo M, Fritz Silva N, Arteaga San Martin R, Alvarez C. [Effects of a six weeks exercise training program for type 2 diabetes mellitus and hypertensive patients]. Rev Med Chil. 2018 Jun;146(6):693-701. doi: 10.4067/s0034-98872018000600693. Spanish.
Reference Type
BACKGROUND
Cano-Montoya J, Ramirez-Campillo R, Martinez C, Sade-Calles F, Salas-Parada A, Alvarez C. [Interaction between antihypertensive therapy and exercise training therapy requires drug regulation in hypertensive patients]. Rev Med Chil. 2016 Feb;144(2):152-61. doi: 10.4067/S0034-98872016000200002. Spanish.
Reference Type
BACKGROUND
Alvarez C, Ramirez-Campillo R, Martinez-Salazar C, Mancilla R, Flores-Opazo M, Cano-Montoya J, Ciolac EG. Low-Volume High-Intensity Interval Training as a Therapy for Type 2 Diabetes. Int J Sports Med. 2016 Aug;37(9):723-9. doi: 10.1055/s-0042-104935. Epub 2016 Jun 3.
Reference Type
BACKGROUND
Cadore EL, Izquierdo M. How to simultaneously optimize muscle strength, power, functional capacity, and cardiovascular gains in the elderly: an update. Age (Dordr). 2013 Dec;35(6):2329-44. doi: 10.1007/s11357-012-9503-x. Epub 2013 Jan 4.
Reference Type
BACKGROUND
Teodoro JL, Izquierdo M, da Silva LXN, Baroni BM, Grazioli R, Lopez P, Fritsch CG, Radaelli R, Saez de Asteasu ML, Bottaro M, Farinha JB, Pinto RS, Cadore EL. Effects of long-term concurrent training to failure or not in muscle power output, muscle quality and cardiometabolic risk factors in older men: A secondary analysis of a randomized clinical trial. Exp Gerontol. 2020 Oct 1;139:111023. doi: 10.1016/j.exger.2020.111023. Epub 2020 Jul 19.
Reference Type
BACKGROUND
Higham SM, Mendham AE, Rosenbaum S, Allen NG, Smith G, Stadnyk A, Duffield R. Effects of concurrent exercise training on body composition, systemic inflammation, and components of metabolic syndrome in inactive academics: a randomised controlled trial. Eur J Appl Physiol. 2023 Apr;123(4):809-820. doi: 10.1007/s00421-022-05108-w. Epub 2022 Dec 6.
Reference Type
BACKGROUND
Alvarez C, Ramirez-Velez R, Ramirez-Campillo R, Lucia A, Alonso-Martinez AM, Faundez H, Cadore EL, Izquierdo M. Improvements cardiometabolic risk factors in Latin American Amerindians (the Mapuche) with concurrent training. Scand J Med Sci Sports. 2019 Jun;29(6):886-896. doi: 10.1111/sms.13409. Epub 2019 Mar 12.
Reference Type
BACKGROUND
Amaro-Gahete FJ, Ponce-Gonzalez JG, Corral-Perez J, Velazquez-Diaz D, Lavie CJ, Jimenez-Pavon D. Effect of a 12-Week Concurrent Training Intervention on Cardiometabolic Health in Obese Men: A Pilot Study. Front Physiol. 2021 Feb 11;12:630831. doi: 10.3389/fphys.2021.630831. eCollection 2021.
Reference Type
BACKGROUND
Gao J, Yu L. Effects of concurrent training sequence on VO2max and lower limb strength performance: A systematic review and meta-analysis. Front Physiol. 2023 Jan 26;14:1072679. doi: 10.3389/fphys.2023.1072679. eCollection 2023.
Reference Type
BACKGROUND
Gibala MJ, Little JP, Macdonald MJ, Hawley JA. Physiological adaptations to low-volume, high-intensity interval training in health and disease. J Physiol. 2012 Mar 1;590(5):1077-84. doi: 10.1113/jphysiol.2011.224725. Epub 2012 Jan 30.
Reference Type
BACKGROUND
Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014 Nov 6;159(4):738-49. doi: 10.1016/j.cell.2014.10.029.
Reference Type
BACKGROUND
Coffey VG, Hawley JA. The molecular bases of training adaptation. Sports Med. 2007;37(9):737-63. doi: 10.2165/00007256-200737090-00001.
Reference Type
BACKGROUND
Goodpaster BH, Sparks LM. Metabolic Flexibility in Health and Disease. Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015.
Reference Type
BACKGROUND
Freese J, Klement RJ, Ruiz-Nunez B, Schwarz S, Lotzerich H. The sedentary (r)evolution: Have we lost our metabolic flexibility? F1000Res. 2017 Oct 2;6:1787. doi: 10.12688/f1000research.12724.2. eCollection 2017.
Reference Type
BACKGROUND
Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72. doi: 10.1111/sms.12581.
Reference Type
BACKGROUND
Islam H, Gibala MJ, Little JP. Exercise Snacks: A Novel Strategy to Improve Cardiometabolic Health. Exerc Sport Sci Rev. 2022 Jan 1;50(1):31-37. doi: 10.1249/JES.0000000000000275.
Reference Type
BACKGROUND
Thornton JS, Fremont P, Khan K, Poirier P, Fowles J, Wells GD, Frankovich RJ. Physical activity prescription: a critical opportunity to address a modifiable risk factor for the prevention and management of chronic disease: a position statement by the Canadian Academy of Sport and Exercise Medicine. Br J Sports Med. 2016 Sep;50(18):1109-14. doi: 10.1136/bjsports-2016-096291. Epub 2016 Jun 22.
Reference Type
BACKGROUND
Moore CG, Carter RE, Nietert PJ, Stewart PW. Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci. 2011 Oct;4(5):332-7. doi: 10.1111/j.1752-8062.2011.00347.x.
Reference Type
BACKGROUND
Christensen E. Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol. 2007 May;46(5):947-54. doi: 10.1016/j.jhep.2007.02.015. Epub 2007 Mar 9.
Reference Type
BACKGROUND
Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016 Jun;25(3):1057-73. doi: 10.1177/0962280215588241. Epub 2015 Jun 19.
Reference Type
BACKGROUND
Takahashi H, Yoshika M, Yokoi T. Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500F. Blood Press Monit. 2015 Apr;20(2):92-7. doi: 10.1097/MBP.0000000000000096.
Reference Type
BACKGROUND
Pleus S, Baumstark A, Schauer S, Kolle J, Jendrike N, Mende J, Haug C, Freckmann G. User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results. J Diabetes Sci Technol. 2024 May;18(3):644-652. doi: 10.1177/19322968221141926. Epub 2022 Nov 26.
Reference Type
BACKGROUND
Coqueiro Rda S, Santos MC, Neto Jde S, Queiroz BM, Brugger NA, Barbosa AR. Validity of a portable glucose, total cholesterol, and triglycerides multi-analyzer in adults. Biol Res Nurs. 2014 Jul;16(3):288-94. doi: 10.1177/1099800413495953. Epub 2013 Jul 19.
Reference Type
BACKGROUND
Huang L, Liu Y, Lin T, Hou L, Song Q, Ge N, Yue J. Reliability and validity of two hand dynamometers when used by community-dwelling adults aged over 50 years. BMC Geriatr. 2022 Jul 15;22(1):580. doi: 10.1186/s12877-022-03270-6.
Reference Type
BACKGROUND
Geeta A, Jamaiyah H, Safiza MN, Khor GL, Kee CC, Ahmad AZ, Suzana S, Rahmah R, Faudzi A. Reliability, technical error of measurements and validity of instruments for nutritional status assessment of adults in Malaysia. Singapore Med J. 2009 Oct;50(10):1013-8.
Reference Type
BACKGROUND
Vasold KL, Parks AC, Phelan DML, Pontifex MB, Pivarnik JM. Reliability and Validity of Commercially Available Low-Cost Bioelectrical Impedance Analysis. Int J Sport Nutr Exerc Metab. 2019 Jul 1;29(4):406-410. doi: 10.1123/ijsnem.2018-0283.
Reference Type
BACKGROUND
Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR; Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002 Apr;77(4):371-83. doi: 10.4065/77.4.371.
Reference Type
BACKGROUND
Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J Man Manip Ther. 2009;17(3):163-70. doi: 10.1179/jmt.2009.17.3.163.
Reference Type
BACKGROUND
Alvarez C, Ramirez-Campillo R, Lucia A, Ramirez-Velez R, Izquierdo M. Concurrent exercise training on hyperglycemia and comorbidities associated: Non-responders using clinical cutoff points. Scand J Med Sci Sports. 2019 Jul;29(7):952-967. doi: 10.1111/sms.13413. Epub 2019 Apr 9.
Reference Type
BACKGROUND
Ciolac EG, Mantuani SS, Neiva CM, Verardi C, Pessoa-Filho DM, Pimenta L. Rating of perceived exertion as a tool for prescribing and self regulating interval training: a pilot study. Biol Sport. 2015 Jun;32(2):103-8. doi: 10.5604/20831862.1134312. Epub 2015 Jan 15.
Reference Type
BACKGROUND
Robertson RJ, Goss FL, Rutkowski J, Lenz B, Dixon C, Timmer J, Frazee K, Dube J, Andreacci J. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc. 2003 Feb;35(2):333-41. doi: 10.1249/01.MSS.0000048831.15016.2A.
Reference Type
BACKGROUND
Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, Carty C, Chaput JP, Chastin S, Chou R, Dempsey PC, DiPietro L, Ekelund U, Firth J, Friedenreich CM, Garcia L, Gichu M, Jago R, Katzmarzyk PT, Lambert E, Leitzmann M, Milton K, Ortega FB, Ranasinghe C, Stamatakis E, Tiedemann A, Troiano RP, van der Ploeg HP, Wari V, Willumsen JF. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.
Reference Type
BACKGROUND
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5352023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Health Education Programme Through Physical Exercise for People With Severe Mental Disorders
NCT06069739
COMPLETED
NA
Effect of Aerobic Exercise on Blood Pressure Changes
NCT00358137
COMPLETED
NA
Examining Psychosocial Mediators of Exercise Behavior
NCT00142688
COMPLETED
PHASE1
Individual Variability to Aerobic Exercise Training
NCT02868710
COMPLETED
NA
Effectiveness of Non-pharmacological Interventions in Patients With Cardiovascular Risk Factors in Primary Care
NCT03452709
COMPLETED
NA
Acute Effect of Individual Variants of Agonist-antagonist and Traditional Agonistic Resistance Training on Cardiovascular Parameters
NCT06047678
ACTIVE_NOT_RECRUITING
NA
Concurrent Training and Metabolic Profile, Lung Function, Quality of Life and Stress
NCT04868240
COMPLETED
NA
Relationship Between Aerobic Prescription Methods
NCT02660450
UNKNOWN
NA
A 12-week Intervention With Motivational Interviewing and Physical Activity Monitoring, to Enhance the Daily Amount of Physical Activity in Community Dwelling Older Adults - a Randomized Controlled Trial
NCT03906162
COMPLETED
NA
Modifications in Cardiovascular Risk Factors When Performing Physical Exercise in Hypertensive and Dyslipidemic Patients
NCT04832048
COMPLETED
NA
The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women
NCT03752060
COMPLETED
NA
A Lifestyle Physical Activity Intervention for Older Sedentary Women
NCT01707693
COMPLETED
NA
Variation of Aortic Compliance Related to Exercise Training With or Without Supervised Sessions
NCT01939080
UNKNOWN
NA
Effects of Mental Practice and Therapeutic Exercise in Mild Smokers
NCT06123598
COMPLETED
NA
Multicomponent Training Combined With Multi-professional Intervention Health Status in Hypertensive and Normotensive Older Women
NCT07152158
ACTIVE_NOT_RECRUITING
NA
Optimal Exercise Regimens for Persons at Increased Risk
NCT00000523
COMPLETED
PHASE2
Effects of Different Moderate-intensity Exercise Methods on Health in the Elderly
NCT05207501
COMPLETED
NA
Effect of Exercise and Heat Stress on Acute Cardiometabolic Adaptations in Healthy Young Adults
NCT06872762
RECRUITING
NA
Boxing Training, Physical-functional Fitness and Cognitive Performance in Older Adults
NCT05826314
ACTIVE_NOT_RECRUITING
NA
Effect of Two Years of Resistance Training in Cardiac Function in Older Women: a Randomized Controlled Trial
NCT06160141
COMPLETED
NA
Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders
NCT02858102
UNKNOWN
NA
Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk
NCT01903941
COMPLETED
PHASE2
Personalized Moderate Intensity Exercise Training Combined With High Intensity Interval
NCT03568214
UNKNOWN
NA
Effects of Two Water-based Aerobic Training Programs in Elderly Women
NCT03289091
COMPLETED
NA
12 Weeks of Water Aerobics at Various Intensities for Adults and Older Adults
NCT06509217
COMPLETED
NA